Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial
Main Authors: | Yingling Zu, Ruirui Gui, Zhen Li, Juan Wang, Yanli Zhang, Fengkuan Yu, Huifang Zhao, Xinrong Zhan, Zhongliang Wang, Pengtao Xing, Xianjing Wang, Huili Wang, Yongping Song, Jian Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-01-01
|
Series: | Blood Cancer Journal |
Online Access: | https://doi.org/10.1038/s41408-022-00771-w |
Similar Items
-
Low-dose ATG combined with low-dose PTCY in preventing GVHD after haploidentical transplantation: a retrospective analysis of 90 cases
by: LEI Jinmei, et al.
Published: (2024-02-01) -
Venetoclax-Azacitidine Bridging PTCy-haplo-PBSCT for Refractory Acute Myeloid Leukemia with IDH2 Mutations
by: Yusuke Daido, et al.
Published: (2023-09-01) -
PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation
by: Olaf Penack, et al.
Published: (2024-03-01) -
Lower dose of ATG combined with basiliximab for haploidentical hematopoietic stem cell transplantation is associated with effective control of GVHD and less CMV viremia
by: Zhenli Huang, et al.
Published: (2022-11-01) -
GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT
by: Frédéric Baron, et al.
Published: (2023-02-01)